![Joanne M. Conroy M.D. Chairperson's File 900x400 as of 2-26-24](/sites/default/files/2024-02/joanne-m-conroy-md-chairpersons-file-900x400-as-of-2-26-2024.jpg)
The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug programs for contract year 2025 intended to improve access to behavioral health care; cap and standardize MA plan compensation to brokers, including prohibiting volume-based bonuses for enrollment into certain plans; limit the distribution of personal beneficiary data by third-party marketing organizations; ensure that MA plans offer appropriate supplemental benefits; streamline enrollment for individuals dually eligible for Medicare and Medicaid; and annually review MA utilization management policies for health equity considerations.